Limited miR-17-92 overexpression drives hematologic malignancies

Limited miR-17-92 overexpression drives hematologic malignancies

Item
http://www.wikidata.org/entity/Q41962072
The MYC/miR-17-92 axis in lymphoproliferative disorders: A common pathway with therapeutic potentialKey genes expressed in different stages of spinal cord ischemia/reperfusion injury.The role of microRNAs in the pathogenesis of HIV-related lymphomas.Alterative Expression and Localization of Profilin 1/VASPpS157 and Cofilin 1/VASPpS239 Regulates Metastatic Growth and Is Modified by DHA Supplementation.Biological Response Modifier in Cancer Immunotherapy.MicroRNAs in esophageal squamous cell carcinoma: Potential biomarkers and therapeutic targets.miRNAs in B Cell Development and Lymphomagenesis.ADAR1 Activation Drives Leukemia Stem Cell Self-Renewal by Impairing Let-7 Biogenesis.Detection of Serum microRNAs From Department of Defense Serum Repository: Correlation With Cotinine, Cytokine, and Polycyclic Aromatic Hydrocarbon Levels.Expression, regulation and mechanism of action of the miR-17-92 cluster in tumor cells (Review).MicroRNAs as Biomarkers of B-cell Lymphoma
P2860

Limited miR-17-92 overexpression drives hematologic malignancies

Item
http://www.wikidata.org/entity/Q41962072
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Limited miR-17-92 overexpression drives hematologic malignancies
@en
type
label
Limited miR-17-92 overexpression drives hematologic malignancies
@en
prefLabel
Limited miR-17-92 overexpression drives hematologic malignancies
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P698
P921
P932
P356
P1433
P1476
Limited miR-17-92 overexpression drives hematologic malignancies
@en
P2093
P2860
P304
P31
P356
10.1016/J.LEUKRES.2014.12.002
P433
P478
P50
P577
P698
P921
P932